Startseite Identification of SLPI (Secretory Leukocyte Protease Inhibitor) in Human Mast Cells Using Immunohistochemistry and In Situ Hybridisation
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Identification of SLPI (Secretory Leukocyte Protease Inhibitor) in Human Mast Cells Using Immunohistochemistry and In Situ Hybridisation

  • U. Westin , å. Polling , I. Ljungkrantz und K. Ohlsson
Veröffentlicht/Copyright: 1. Juni 2005
Biological Chemistry
Aus der Zeitschrift Band 380 Heft 4

Abstract

Recently interest has been focused on secretory leucocyte protease inhibitor (SLPI) and its role in immediate hypersensitive reactions, possibly by inhibiting mast cell chymase. The purpose of this investigation was to show whether or not SLPI is produced in mast cells.

Double-immunolabelling revealed that SLPI coexists with mast cell tryptase (60%) and chymase (37%). On the other hand, in situ hybridisation studies demonstrated the expression of SLPI mRNA in all mast cells. The differences in results can be attributed to the fact that in situ hybridisation is a more sensitive method than immunohistochemistry. Hence, we conclude that SLPI is produced in human tonsillar mast cells.

:
Published Online: 2005-06-01
Published in Print: 1999-04-01

Copyright © 1999 by Walter de Gruyter GmbH & Co. KG

Heruntergeladen am 2.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/BC.1999.063/html
Button zum nach oben scrollen